The program, funded by Bayer Healthcare Pharmaceuticals, is in its second year and aims to advance the scientific understanding and clinical managent of retinal ophthalmic disorders.
A total of six grants, each worth up to US$50,000, supporting research and training in retinal ophthalmology, will be awarded to successful applicants from across the world. The grants include three Fellowship Project Awards, intended to facilitate the development of research and clinical expertise in the field of retinal ophthalmology, and three Research Awards, which aim to support a wide range of clinical and/or basic research projects in retinal ophthalmology.
Australian medical retinal and macular specialist, and chair of the independent judging committee, Dr Jennifer Arnold, said the committee is once again looking forward to receiving submissions for pioneering project proposals in 2013.
“Whether it provides an opportunity to advance treatment options, improve patient outcomes or encourage ophthalmologists to further develop their skills in the managent of retinal disorders, the program presents an exciting opportunity,” Dr Arnold said.
Submissions close in April.
Plenty of interest in RxSight’s Light Adjustable Lens at AUSCRS
RxSight believes Australian cataract surgeons are ready to embrace a technology that has already transformed refractive cataract surgery overseas, using...
